Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys

[1]  R. Roth,et al.  Novel Radioligands for the Dopamine Transporter Demonstrate the Presence of Intrastriatal Nigral Grafts in the MPTP-Treated Monkey: Correlation with Improved Behavioral Function , 1994, Experimental Neurology.

[2]  R. Roth,et al.  Fetal Dopamine Cell Survival after Transplantation Is Dramatically Improved at a Critical Donor Gestational Age in Nonhuman Primates , 1993, Experimental Neurology.

[3]  W. Landau.  Clinical neuromythology X. Faithful fashion: survival status of the brain transplant cure for parkinsonism. , 1993, Neurology.

[4]  B J Hoffer,et al.  Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. , 1992, The Journal of pharmacology and experimental therapeutics.

[5]  G. Nilaver,et al.  Tyrosine hydroxylase expression in non-catecholaminergic cells in cerebellar cultures , 1992, Brain Research.

[6]  I. Nagatsu,et al.  Do some tyrosine hydroxylase-immunoreactive neurons in the human ventrolateral arcuate nucleus and globus pallidus produce only l-DOPA? , 1991, Neuroscience Letters.

[7]  K. Gale,et al.  Pharmacological evidence for feedback regulation of dopamine metabolism in solid fetal substantia nigra transplants. , 1990, The Journal of pharmacology and experimental therapeutics.

[8]  W. Landau.  Clinical Neuromythology VII Artificial intelligence , 1990, Neurology.

[9]  D. Jacobowitz,et al.  The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. , 1990, Journal of neurosurgery.

[10]  R. Roth,et al.  Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions , 1989, Neuroscience.

[11]  J. Kordower,et al.  Adrenal medullary autografts into the basal ganglia of Cebus monkeys: Injury-induced regeneration , 1988, Experimental Neurology.

[12]  A. Björklund,et al.  Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. , 1988, Brain research.

[13]  R. Roth,et al.  Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF , 1987, Brain Research.

[14]  A. Björklund,et al.  Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis , 1987, Neuroscience.

[15]  R. Roth,et al.  Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum. , 1987, Life sciences.

[16]  S. Wiegand,et al.  Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology , 1986, Peptides.

[17]  M. Moal,et al.  Activation of striatal dopaminergic grafts by haloperidol , 1985, Brain Research Bulletin.

[18]  C. Marsden,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset , 1984, Neuroscience Letters.

[19]  M. Zigmond,et al.  Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. , 1984, Archives of neurology.

[20]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[22]  A. Björklund,et al.  Functional Activity of Substantia Nigra Grafts Reinnervating the Striatum: Neurotransmitter Metabolism and [14C]2‐Deoxy‐d‐glucose Autoradiography , 1982, Journal of neurochemistry.

[23]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  R. Wurtman,et al.  Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization , 1980, Brain Research.

[25]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[26]  Y. Agid,et al.  Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. , 1973, Nature: New biology.

[27]  R. Roth,et al.  Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys. , 1995, Cell transplantation.

[28]  R. Roth,et al.  Behavioral Effects of MPTP Administration in the Vervet Monkey , 1994 .

[29]  R. Roth,et al.  Cellular replacement of dopamine deficit in Parkinson's disease using human fetal mesencephalic tissue: preliminary results in four patients. , 1993, Research publications - Association for Research in Nervous and Mental Disease.

[30]  W. Freed.  Substantia nigra grafts and Parkinson's disease: from animal experiments to human therapeutic trials. , 1991, Restorative neurology and neuroscience.

[31]  D. Jacobowitz,et al.  Fetal nondopaminergic neural implants in parkinsonian primates. Histochemical and behavioral studies. , 1991, Journal of neurosurgery.

[32]  R. Penn,et al.  Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned rat. , 1991, Journal of neurosurgery.

[33]  J. Kordower,et al.  Striatal adrenal medulla/sural nerve cografts in hemiparkinsonian monkeys. , 1990, Progress in brain research.

[34]  C. Marsden,et al.  A functional assessment of embryonic dopaminergic grafts in the marmoset. , 1990, Progress in brain research.

[35]  D. Jacobowitz,et al.  Transient behavioral recovery in hemiparkinsonian primates after adrenal medullary allografts. , 1988, Progress in brain research.

[36]  R. Roth,et al.  Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. , 1988, Progress in brain research.

[37]  S. Hunt,et al.  Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1988, Progress in brain research.

[38]  A. Hendrickx,et al.  Prenatal growth in the cynomolgus and rhesus macaque (Macaca fascicularis and Macaca mulatta): A comparison by ultrasonography , 1988, American journal of primatology.

[39]  K. M. Sweeney,et al.  Chapter 60 Delayed stereotactic transplantation technique in non-human primates , 1988 .

[40]  R. Bakay,et al.  Preliminary report on the use of fetal tissue transplantation to correct MPTP-induced Parkinson-like syndrome in primates. , 1985, Applied neurophysiology.

[41]  F. Gage,et al.  Intracerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. , 1983, Acta physiologica Scandinavica. Supplementum.